The recall includes both losartan potassium tablets and losartan potassium hydrochlorothiazide tablets.
The recall is due to the presence of N-Nitroso N-Methyl 4-aminobutyric acid, a potential human carcinogen. Torrent already recalled three lots of losartan on March 15 and 114 lots of losartan on March 1.
Torrent’s recall is the latest in a string of voluntary recalls by distributors and drugmakers related to a class of drugs known as angiotensin II receptor blockers, used to control blood pressure. The recalls are related to the detection of various cancer-causing impurities.
Read the full recall notice here.
More articles on pharmacy:
PBM hearing should prompt bill to ban ‘secrecy’ in drug industry, senator says
Republicans tell drugmakers that complying with House probe could hurt their stock prices
Hawaii primary care network opens in-house pharmacy